Archive: 09/01/2018
NeuroNext biomarker study explores natural history of infantile-onset SMA
Research led by The Ohio State University Wexner Medical Center to define the natural history of infantile-onset spinal muscular atrophy (SMA) has been "critical" to accelerate the development of effective therapies and hasten ...
Jan 9, 2018